Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer ; day:27 ; month:4 ; year:2016 ; pages:1-14
Breast cancer research and treatment ; (27.4.2016), 1-14
- Urheber
-
Thakkar, A.
- Beteiligte Personen und Organisationen
-
Wang, B.
Picon-Ruiz, M.
Buchwald, P.
Ince, Tan A.
SpringerLink (Online service)
- DOI
-
10.1007/s10549-016-3807-y
- URN
-
urn:nbn:de:1111-201604297591
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thakkar, A.
- Wang, B.
- Picon-Ruiz, M.
- Buchwald, P.
- Ince, Tan A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer